My focus is solely on sensitivity and specificity. How soon we forget that there presently are no markers for lung, breast,stomach, ovarian, bladder, kidney, liver, and what markers we presently do have are not nearly as accurate as Recaf, so you all can debate all you want whether this is happening or who said what to whom, but my money is on Recaf and it will remain as long as we continue to get consistent stellar results. That is the one thing you don't have to speculate on and that is why I will continue to support this company. I don't have rose colored glasses on. My opinion is based soley on data that has and will continue to blow away what present medicine has to offer, and yes I have yesterday and today added to my position.
News 
Market Data 
Discover 
